Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Quantitative EEG in Schizophrenic Patients before and during Pharmacotherapy (CROSBI ID 130067)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Begić, Dražen ; Hotujac, Ljubomir ; Jokić-Begić, Nataša Quantitative EEG in Schizophrenic Patients before and during Pharmacotherapy // Neuropsychobiology, 41 (2000), 3; 166-170-x

Podaci o odgovornosti

Begić, Dražen ; Hotujac, Ljubomir ; Jokić-Begić, Nataša

engleski

Quantitative EEG in Schizophrenic Patients before and during Pharmacotherapy

The aim of the study was to determine the possible differences in quantitative EEG parameters of schizophrenic patients before and during therapy with neuroleptics. First EEG recordings were obtained from schizophrenic patients (n = 50) who had not been taking any medicaments during the preceding 2 months. Second EEG recordings were obtained during the administration of neuroleptic therapy. Amplitude values of particular spectral segment, i.e. delta, theta, alpha 1, alpha 2, beta 1 and beta 2 (after fast Fourier transformation) were analyzed. The F3, F4, C3, C4, T3, T4, P3, P4, O1 and O2 regions were observed. The effect of pharmacotherapy manifested as a decrease in delta and beta 2 activities. The alterations of the delta spectrum were recorded in each patient subgroup (regardless of the neuroleptic used). The changes in beta 2 activity were registered in patients on haloperidol and fluphenazine.

schizophrenia; drug-free patients; neuroleptics; EEG

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

41 (3)

2000.

166-170-x

objavljeno

0302-282X

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost